Literature DB >> 21369868

Diagnosis and treatment of primary aldosteronism.

Gian Paolo D Rossi1.   

Abstract

Primary aldosteronism involves more than 11% of hypertensive patients who are referred to specialized centers for the diagnosis and treatment of hypertension. If not diagnosed early it causes an excess damage to the heart, vessels and kidney, which translates into an cardiovascular events. Since these ominous consequences can be corrected with a timely diagnosis and an appropriate therapy, physicians should exercise a high degree of alert concerning the possibility that primary aldosteronism is present in hypertensive patients. The purpose of this review is to provide up-dated information on the strategy for case detection, the subtype differentiation and the management of primary aldosteronism.

Entities:  

Mesh:

Year:  2011        PMID: 21369868     DOI: 10.1007/s11154-011-9162-8

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  105 in total

1.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

Review 2.  Plasma renin and aldosterone measurements in low renin hypertensive states.

Authors:  Jean E Sealey; Richard D Gordon; Franco Mantero
Journal:  Trends Endocrinol Metab       Date:  2005-04       Impact factor: 12.015

3.  The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma.

Authors:  Gian Paolo Rossi; Marlena Barisa; Anna Belfiore; Giovambattista Desideri; Claudio Ferri; Claudio Letizia; Mauro Maccario; Alberto Morganti; Gaetana Palumbo; Anna Patalano; Elisabetta Roman; Teresa M Seccia; Achille C Pessina; Franco Mantero
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

4.  Role for adrenal venous sampling in primary aldosteronism.

Authors:  William F Young; Anthony W Stanson; Geoffrey B Thompson; Clive S Grant; David R Farley; Jon A van Heerden
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

5.  Aldosterone induces a vascular inflammatory phenotype in the rat heart.

Authors:  Ricardo Rocha; Amy E Rudolph; Gregory E Frierdich; Denise A Nachowiak; Beverly K Kekec; Eric A G Blomme; Ellen G McMahon; John A Delyani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

Review 6.  Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases.

Authors:  Brian K P Goh; Yeh-Hong Tan; Kenneth T E Chang; Peter H K Eng; Sidney K H Yip; Christopher W S Cheng
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

7.  Coexistence of aldosteronoma and contralateral nonfunctioning adrenal adenoma in primary aldosteronism.

Authors:  F Fallo; L Barzon; M Boscaro; N Sonino
Journal:  Am J Hypertens       Date:  1997-04       Impact factor: 2.689

8.  Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma.

Authors:  G P Rossi; A Sacchetto; E Pavan; P Palatini; G R Graniero; C Canali; A C Pessina
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

9.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

Review 10.  Primary aldosteronism: an update on screening, diagnosis and treatment.

Authors:  Gian Paolo Rossi; Achille Cesare Pessina; Anthony M Heagerty
Journal:  J Hypertens       Date:  2008-04       Impact factor: 4.844

View more
  5 in total

1.  Comparison of C-arm computed tomography and on-site quick cortisol assay for adrenal venous sampling: A retrospective study of 178 patients.

Authors:  Chin-Chen Chang; Bo-Ching Lee; Yeun-Chung Chang; Vin-Cent Wu; Kuo-How Huang; Kao-Lang Liu
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

2.  MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.

Authors:  Guoxi Zhang; Xiaofeng Zou; Quanliang Liu; Tianpeng Xie; Ruohui Huang; Huan Kang; Changfu Lai; Jiaxing Zhu
Journal:  Int J Exp Pathol       Date:  2018-04-17       Impact factor: 1.925

3.  Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.

Authors:  N Wada; Y Shibayama; H Umakoshi; T Ichijo; Y Fujii; K Kamemura; T Kai; R Sakamoto; A Ogo; Y Matsuda; T Fukuoka; M Tsuiki; T Suzuki; M Naruse
Journal:  J Hum Hypertens       Date:  2017-05-25       Impact factor: 3.012

Review 4.  Management of hypertension in primary aldosteronism.

Authors:  Anna Aronova; Thomas J Fahey; Rasa Zarnegar
Journal:  World J Cardiol       Date:  2014-05-26

5.  Non-stimulated adrenal venous sampling using Dyna computed tomography in patients with primary aldosteronism.

Authors:  Chin-Chen Chang; Bo-Ching Lee; Kao-Lang Liu; Yeun-Chung Chang; Vin-Cent Wu; Kuo-How Huang
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.